COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

Bullboard Posts

Comment by Roverthingon Nov 11, 2015 4:36pm

104 Views

Post# 24282606

RE:RE:RE:Predicting the reverse split on AEZ AEZS

Don't be surprised if the SP continues to go down. Because most of the shareholders don't like share consolidation at all. Because mostly when they do that the SP decreases after the consolidation. It is not the first share consolidation here. Be careful. Good luck! IMO

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment